An Interview With AACR’s President-Elect
April 22nd 2015In this interview with ONCOLOGY Editor-in-Chief Nancy Davidson, MD, we dive into the “gray area” of breast biopsies and how the oncology community can meet this challenge. Dr. Davidson, AACR’s president-elect, also discusses the changes she has seen during her career with regard to how cancer patients are treated and looks forward during this optimistic time in treatment and research.
Oral Metabolism Drug Active in Acute Myeloid Leukemia
April 7th 2014New trial results show that a novel, oral metabolic inhibitor has demonstrated early activity in relapsed or refractory acute myeloid leukemia (AML), according to data presented at the annual meeting of the American Association of Cancer Research.
Multidisciplinary Care: Tap Into the Nonclinical Care Force
April 3rd 2014Multidisciplinary care teams are an important aspect of patient-centered care and are slowly become more common place at community cancer centers. For those working at smaller hospitals or centers, it is important to use every type of resource available and in a lot of cases those resources include the nonclinical care force including family members, clergy, and volunteers.
Cancer Centers Must Differentiate, Become Essential in Order to Capture Growth
April 3rd 2014By the year 2020 it is estimated that about 18% of the US population will be Medicare eligible and growing advances in the treatment of cancer have significantly increased the number of cancer survivors. These two growing populations have large implications on the demand for cancer services.
Tips to Comply With New Commission on Cancer Standards
April 2nd 2014In 2011, the American College of Surgeons Commission on Cancer announced several new patient-centered standards that were designed to ensure that key elements of quality cancer care are provided to every person with cancer treated at an accredited facility.
Multidisciplinary Care: How Small Practices, Hospitals Can Gain Support to Establish Teams
April 2nd 2014In a session at the ACCC 40th Annual National Meeting, panel members offered advice for smaller practices who want to create multidisciplinary teams but who might not have financial or C-suite support.
AACR: Results of THYME Trial Show the Time Is Not Right for AZD8931
April 11th 2013The THYME trial testing AZD8931 in advanced HER2-low breast cancer failed to reach the primary endpoint of progression-free survival, according to results of the phase II trial presented at the 2013 AACR meeting in Washington, DC.
AACR: Immunotherapy Antibody Has Activity in Range of Solid Tumors
April 10th 2013The anti-PD-L1 antibody MPDL3280A is effective for several different cancers and was well tolerated. Responses were seen in lung, kidney, colon, and stomach cancer patients. All patients who responded are continuing to respond to the treatment.